Market overview
The global fat modular nutrition market is worth USD 147 mn in 2026 and is forecast to reach USD 239 mn by 2036, growing at a 5.0% CAGR. United States is the largest country market and MCT oil and emulsions is the largest by type segment.
| Scope | Concentrated fat and MCT oil supplements added to feeds and meals to raise energy intake in patients with malnutrition, epilepsy diets and fat malabsorption. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 140 mn |
| Value 2026 | USD 147 mn |
| Value 2036 | USD 239 mn |
| CAGR 2026-2036 | 5.0% |
| Volume 2026 | 7,313 thousand litres |
| Volume 2036 | 11,333 thousand litres |
| Average price 2026 | USD 20.1 per litre |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Fat Modular Nutrition market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 147 mn |
| 2027 | USD 154 mn |
| 2028 | USD 162 mn |
| 2029 | USD 170 mn |
| 2030 | USD 179 mn |
| 2031 | USD 188 mn |
| 2032 | USD 197 mn |
| 2033 | USD 207 mn |
| 2034 | USD 217 mn |
| 2035 | USD 228 mn |
| 2036 | USD 239 mn |
Fat Modular Nutrition market segmentation
By type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| MCT oil and emulsions | 48.0% | 50.0% | USD 71 mn | 5.4% |
| Long-chain fat emulsions | 34.0% | 32.2% | USD 50 mn | 4.4% |
| Powder fat modules | 18.0% | 17.9% | USD 26 mn | 4.9% |
By use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Malnutrition and oncology | 40.0% | 40.0% | USD 59 mn | 5.0% |
| Paediatric and ketogenic diets | 30.0% | 31.4% | USD 44 mn | 5.5% |
| Malabsorption and surgery | 30.0% | 28.6% | USD 44 mn | 4.5% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 44.0% | 40.0% | USD 65 mn | 4.0% |
| Home care | 34.0% | 38.0% | USD 50 mn | 6.2% |
| Long-term care | 22.0% | 22.0% | USD 32 mn | 5.0% |
By patient age group
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Infants and children | 28.0% | 27.0% | USD 41 mn | 4.6% |
| Adults | 44.0% | 43.0% | USD 65 mn | 4.8% |
| Elderly | 28.0% | 30.0% | USD 41 mn | 5.7% |
By distribution
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospital pharmacy | 38.0% | 34.0% | USD 56 mn | 3.8% |
| Retail pharmacy | 30.0% | 28.0% | USD 44 mn | 4.3% |
| Online | 18.0% | 26.0% | USD 26 mn | 8.9% |
| Direct from manufacturer | 14.0% | 12.0% | USD 21 mn | 3.4% |
Top 25 countries for fat modular nutrition by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 82.0% of 2026 revenue and the 25 countries below together hold 95.3%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 47 mn | 32.0% | USD 74 mn | 4.6% |
| 2 | Germany | USD 12 mn | 8.0% | USD 18 mn | 4.6% |
| 3 | United Kingdom | USD 12 mn | 8.0% | USD 19 mn | 5.1% |
| 4 | Japan | USD 10 mn | 7.0% | USD 16 mn | 4.5% |
| 5 | France | USD 8.8 mn | 6.0% | USD 14 mn | 4.6% |
| 6 | China | USD 8.8 mn | 6.0% | USD 19 mn | 8.1% |
| 7 | Italy | USD 5.9 mn | 4.0% | USD 9.3 mn | 4.7% |
| 8 | Spain | USD 5.9 mn | 4.0% | USD 9.3 mn | 4.7% |
| 9 | Netherlands | USD 5.1 mn | 3.5% | USD 8.1 mn | 4.7% |
| 10 | Australia | USD 5.1 mn | 3.5% | USD 8.4 mn | 5.0% |
| 11 | Canada | USD 2.6 mn | 1.8% | USD 4.0 mn | 4.3% |
| 12 | Brazil | USD 2.0 mn | 1.4% | USD 3.9 mn | 6.8% |
| 13 | Switzerland | USD 1.8 mn | 1.2% | USD 2.7 mn | 4.4% |
| 14 | South Korea | USD 1.5 mn | 1.0% | USD 2.2 mn | 4.3% |
| 15 | Belgium | USD 1.5 mn | 1.0% | USD 2.2 mn | 4.3% |
| 16 | Sweden | USD 1.5 mn | 1.0% | USD 2.2 mn | 4.3% |
| 17 | Austria | USD 1.2 mn | 0.8% | USD 1.8 mn | 4.3% |
| 18 | India | USD 1.2 mn | 0.8% | USD 2.7 mn | 8.6% |
| 19 | Mexico | USD 1.2 mn | 0.8% | USD 2.2 mn | 6.6% |
| 20 | Denmark | USD 1.2 mn | 0.8% | USD 1.8 mn | 4.3% |
| 21 | Turkey | USD 0.88 mn | 0.6% | USD 1.7 mn | 6.6% |
| 22 | Poland | USD 0.88 mn | 0.6% | USD 1.3 mn | 4.3% |
| 23 | Norway | USD 0.88 mn | 0.6% | USD 1.3 mn | 4.3% |
| 24 | Taiwan | USD 0.88 mn | 0.6% | USD 1.3 mn | 4.3% |
| 25 | Saudi Arabia | USD 0.59 mn | 0.4% | USD 1.1 mn | 6.7% |
| Rest of world | USD 6.8 mn | 4.7% | USD 11 mn | 4.8% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Nestle Health Science
- Danone Nutricia
- Abbott
- Fresenius Kabi
- Mead Johnson Nutrition
Group 2: Regional and specialist players
- Vitaflo
- Nutri Advance
Group 3: Emerging and niche players
- Kate Farms
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the fat modular nutrition market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.0% is calculated from the resulting values.
The market is divided by type, by use, by end user, by patient age group, by distribution. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the fat modular nutrition market?
The global fat modular nutrition market is estimated at USD 140 mn in 2025 and USD 147 mn in 2026.
How fast will the fat modular nutrition market grow?
It is forecast to reach USD 239 mn by 2036, a compound annual growth rate of 5.0% from 2026, an increase of USD 92 mn.
Which country is the largest market for fat modular nutrition?
United States is the largest market by revenue at USD 47 mn in 2026, 32.0% of the global total. The three largest countries together hold 48.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 8.1% a year from 2026 to 2036.
Which fat modular nutrition segment is largest?
In the by type split, MCT oil and emulsions is the largest segment with 48.0% of 2026 revenue.
Who are the leading fat modular nutrition companies?
Global leaders include Nestle Health Science, Danone Nutricia, Abbott, Fresenius Kabi.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Marine ToxinUSD 149 mn · 6.0% CAGR
- Cystic Fibrosis Nutrition ProductsUSD 145 mn · 3.5% CAGR
- AI-Powered Gait & Mobility AnalyticsUSD 151 mn · 11.0% CAGR
- Theranostic Workflow PlatformsUSD 156 mn · 18.0% CAGR
- Dermatology Cryosurgery UnitsUSD 158 mn · 5.0% CAGR
- Otoacoustic Emissions Hearing ScreenerUSD 136 mn · 4.8% CAGR
- Canine Fungal Infection TreatmentUSD 159 mn · 5.5% CAGR
- Immunoadsorption ColumnsUSD 160 mn · 6.5% CAGR
← Extracorporeal Membrane Oxygenation Federated Learning Drug Discovery →